TUCC physicians are known throughout the country for their highly specialized skills. Here are a few links to PDF files and video clips of recent news stories that featured TUCC physicians, patients and our center.
When a test on a polyp came back benign, Joe Erhart, 60, of the Denver-metro area, thought he was in the clear.
"But they did find cancer in one other area," said Erhart.
It was prostate cancer. That triggered an immediate, unquestionable response for Erhart -- fight it, and beat it.
“I feel good about the outcome,” he said. “I think it's going to be okay."
He's one of the first ever patients in the world to be treated with a new technology.
Every March, thousands of men choose to get a vasectomy or vasectomy reversal during the NCAA Tournament. In this segment airing on The FAN Sports Radio, TUCC physician Alex Philpott provides insight into this men's health phenomenon and gives his picks for the rest of the tournament.
The Urology Center of Colorado is the first site in Denver to offer radiation therapy patients the SpaceOAR hydrogel before their first treatment. SpaceOAR creates a space between the prostate and surrounding structures, which allows the radiation beams to target the prostate and minimize side effects. TUCC Radiation Oncologist, Dr. Eric Gross, explains how the technology works in this 850KOA Radio segment.
The Urology Center of Colorado (TUCC) is pioneering a new tool proven to protect prostate cancer patients from the negative effects of radiation therapy. On December 9th, first patient at TUCC will be injected with SpaceOAR hydrogel, the first FDA cleared spacing device to protect the rectum in men undergoing radiation therapy for prostate cancer.
The SpaceOAR System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer, creating space to protect the rectum from radiation exposure. TUCC is the first treatment center in Denver and one of the first centers nationwide to adopt the advanced technology.
The 6th annual Blue Shoe Run is gearing up in Denver.
September is National Prostate Cancer Awareness month. Prostate cancer is the most commonly diagnosed cancer in Colorado, according to organizers.
Lawrence Karsh, MD, FACS, director, Clinical Research Department, The Urology Center of Colorado, discusses the TERRAIN trial, which compared enzalutamide with bicalutamide for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
Congratulations to TUCC physicians Eric Gross, Eli Hsu and Stephen Ruyle on their recognition as 2015 Top Docs by 5280 Magazine.
Denver's Porter Hospital is one of 13 nationwide participating in one of the largest kidney exchange programs ever.
Michelle Martin and Jerome Peralta, both of metro Denver, are part of that chain.
Martin donated her good kidney in exchange for a kidney match for Peralta.
If you need to undergo a simple medical procedure, it turns out this week is a popular one to do it.
With 16 games in the NCAA men’s basketball tournament on Thursday and Friday, men can recover from a vasectomy thanks to endless hours of games on TV.
TUCC urologist, Dr. Stephen Ruyle, is featured in this article on recognizing the signs and symptoms of prostate disease in the 2015 issue of Health and Wellness Magazine.
TUCC is contracted with all major insurance companies. We look forward to providing you with clinically advanced, compassionate urologic care.